Back to search
Upper Extremity Deep Vein Thrombosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Upper Extremity Deep Vein Thrombosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Upper Extremity Deep Vein Thrombosis trials you may qualify forCentral venous (CVC) is essential in modern healthcare but unfortunately associated with complications, including thrombosis. In a recently published study, it…
After hip or knee replacement all patients receive a standardized treatment with blood thinners, this medication is called thrombosis prophylaxis. However, desp…
This trial seeks to evaluate a management strategy after the acute treatment duration (≥ 3 months of therapeutic anticoagulation) for patients with cancer and c…
To evaluate the venous valvular function after pharmacomechanical thrombectomy (PMT) for acute femoral-popliteal venous thrombosis.
This project aims to identify catheter-related thrombosis (CRT) and determine its incidence, associated factors, and outcomes. The eligible patients will underg…
Research Question: In adult SCD patients with CVC, is it feasible and safe to conduct an adequately powered RCT to evaluate the use of rivaroxaban as thrombopr…